Robyn E O'Hehir Selected Research

allergen Hev b 5

5/2003

Characterization of a mouse model of allergy to a major occupational latex glove allergen Hev b 5.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robyn E O'Hehir Research Topics

Disease

26	Hypersensitivity (Allergy) 11/2021 - 03/2002
21	Asthma (Bronchial Asthma) 10/2021 - 03/2002
12	Anaphylaxis (Anaphylactic Shock) 10/2022 - 05/2003
11	Inflammation (Inflammations) 01/2017 - 06/2010
9	Food Hypersensitivity (Food Allergy) 12/2020 - 09/2006
6	Rhinitis 01/2020 - 03/2002
5	Peanut Hypersensitivity (Peanut Allergy) 10/2022 - 01/2007
5	Seasonal Allergic Rhinitis (Hay Fever) 01/2020 - 12/2008
4	Allergic Rhinitis 10/2021 - 01/2012
2	COVID-19 01/2021 - 12/2020
2	Urticaria (Hives) 12/2020 - 01/2019
2	Drug Hypersensitivity (Drug Allergy) 12/2020 - 12/2019
2	Bronchiectasis 01/2019 - 01/2018
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2019 - 01/2018
2	Shellfish Hypersensitivity 01/2019 - 01/2013
2	Pneumonia (Pneumonitis) 01/2017 - 07/2015
2	Lung Diseases (Lung Disease) 07/2015 - 01/2013
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2008 - 09/2006
2	Latex Hypersensitivity (Latex Allergy) 12/2005 - 05/2003
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Convalescence 12/2020
1	Virus Diseases (Viral Diseases) 12/2020
1	Atopic Dermatitis (Atopic Eczema) 12/2020
1	Rhinosinusitis 12/2020
1	Leukemia 10/2020
1	Human Influenza (Influenza) 01/2020
1	Disease Progression 01/2019
1	Bruton type agammaglobulinemia 01/2019
1	Chronic Urticaria 01/2019
1	Reinfection 01/2019
1	Common Variable Immunodeficiency 01/2019
1	AIDS-Related Complex (ARC) 08/2017
1	Weight Gain 01/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Eosinophilia 01/2016
1	Metabolic Diseases (Metabolic Disease) 01/2016
1	Acute-Phase Reaction 01/2016
1	Ischemia 01/2016
1	Cystic Fibrosis (Mucoviscidosis) 07/2015
1	Body Weight (Weight, Body) 07/2015
1	Allergic Bronchopulmonary Aspergillosis 03/2015
1	Thyroiditis 09/2013

Drug/Important Bio-Agent (IBA)

34	AllergensIBA 11/2021 - 03/2002
17	Immunoglobulin E (IgE)IBA 10/2021 - 08/2006
6	activin AIBA 01/2016 - 06/2010
5	CytokinesIBA 01/2016 - 06/2010
5	Proteins (Proteins, Gene)FDA Link 04/2010 - 05/2003
4	VaccinesIBA 01/2021 - 03/2002
4	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2012
4	Immunoglobulin G (IgG)IBA 01/2020 - 01/2018
4	Peptides (Polypeptides)IBA 08/2017 - 03/2011
4	FollistatinIBA 01/2016 - 08/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 03/2015
3	AntigensIBA 01/2020 - 12/2011
3	Polystyrenes (Polystyrene)IBA 01/2017 - 02/2012
2	AntibodiesIBA 12/2020 - 12/2011
2	Biological ProductsIBA 01/2020 - 12/2019
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 08/2017 - 03/2011
2	EpitopesIBA 08/2017 - 02/2016
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2013 - 08/2012
2	hypoxanthine arabinoside (ara-H)IBA 03/2011 - 01/2011
2	Epinephrine (Adrenaline)FDA LinkGeneric 04/2008 - 07/2003
2	LatexIBA 12/2005 - 05/2003
1	COVID-19 VaccinesIBA 10/2021
1	Povidone (Crospovidone)IBA 01/2021
1	Trimethoprim (Proloprim)FDA LinkGeneric 01/2021
1	Nucleocapsid ProteinsIBA 12/2020
1	CollagenIBA 10/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	SPADIBA 01/2018
1	TabletsIBA 01/2018
1	Dac g 5 allergenIBA 08/2017
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2017
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2016
1	OvalbuminIBA 01/2016
1	PlacebosIBA 01/2016
1	CoagulantsIBA 01/2016
1	Heparin (Liquaemin)FDA LinkGeneric 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	aluminum sulfate (alum)IBA 01/2016
1	activin BIBA 01/2016
1	anti-IgE antibodiesIBA 03/2015
1	Monoclonal AntibodiesIBA 03/2015
1	Omalizumab (Xolair)FDA Link 03/2015
1	SilverIBA 05/2014
1	GlucocorticoidsIBA 09/2013
1	Tamoxifen FDA LinkGeneric 09/2013
1	Rituximab (Mabthera)FDA Link 09/2013

Therapy/Procedure

12	Immunotherapy 01/2020 - 03/2002
6	Therapeutics 12/2020 - 01/2007
2	Lung Transplantation 10/2022 - 01/2016
2	Precision Medicine 12/2019 - 12/2018
1	Injections 10/2021
1	Self Medication 01/2019
1	Treatment Delay 01/2018
1	Surgical Decompression 09/2013